Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$914,175.00

Overcoming barriers to antibiotic production in Streptomyces bacteria

FY 2018-19

Summary
Antibiotic resistance is fast becoming a global health crisis: disease-causing bacteria are no longer killed by existing antibiotics, and we urgently need new drugs to help treat infectious disease. Most antibiotics are made by bacteria called 'Streptomyces'. It turns out that Streptomyces have the ability to make far greater numbers of antibiotics than anyone has ever seen - the only problem being that most antibiotics are not made when Streptomyces are grown in the laboratory. We have discovered a protein that acts as a major roadblock for antibiotic production in Streptomyces: if you get rid of this protein, many new antibiotics are made. We are using this knowledge to turn on the production of new antibiotics in many Streptomyces (each one has unique antibiotic capabilities). Our findings have the potential to help deal with the impending antibiotic resistance crisis, and will provide tools that will enable future drug discovery.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
390484
Name
Elliot Marie A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Overcoming barriers to antibiotic production in Streptomyces bacteria
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$914,175
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antibiotics; Cryptic Antibiotic Clusters; Gene Regulation; Heterologous Expression; Microbial Genetics; Molecular Biology; Morphological Development; Nucleoid-Associated Proteins; Spatial Segregation; Streptomyces
Abstract
Antibiotic resistance is fast becoming a global health crisis: disease-causing bacteria are no longer killed by existing antibiotics, and we urgently need new drugs to help treat infectious disease. Most antibiotics are made by bacteria called 'Streptomyces'. It turns out that Streptomyces have the ability to make far greater numbers of antibiotics than anyone has ever seen - the only problem being that most antibiotics are not made when Streptomyces are grown in the laboratory. We have discovered a protein that acts as a major roadblock for antibiotic production in Streptomyces: if you get rid of this protein, many new antibiotics are made. We are using this knowledge to turn on the production of new antibiotics in many Streptomyces (each one has unique antibiotic capabilities). Our findings have the potential to help deal with the impending antibiotic resistance crisis, and will provide tools that will enable future drug discovery.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Elliot, Marie A
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $914,175~ $0~